More IVD Consolidation as Beckman Coulter Buys Diagnostics Business of Olympus

Acquisition will particularly strengthen Beckman’s presence in clinical chemistry market Monday, March 2, 2009 Last Friday, Beckman Coulter Inc. (NYSE:BEC) announced that it will pay $800 million acquire the diagnostics business of Olympus Corporation. This is a major transaction that further consolidates the in vitro diagnostics (IVD) industry, particularly given the respective market shares in clinical chemistry currently held by both Beckman and Olympus. A Japanese firm headquartered...
;